Inhibition of the mitochondrial permeability transition by protein kinase A in rat liver mitochondria and hepatocytes
- 11 October 2010
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 431 (3) , 411-421
Abstract
NO and cGMP administered at reperfusion after ischaemia prevent injury to hepatocytes mediated by the MPT (mitochondrial permeability transition). To characterize further the mechanism of protection, the ability of hepatic cytosol in combination with cyclic nucleotides to delay onset of the calcium-induced MPT was evaluated in isolated rat liver mitochondria. Liver cytosol plus cGMP or cAMP dose-dependently inhibited the MPT, required ATP hydrolysis for inhibition and did not inhibit mitochondrial calcium uptake. Specific peptide inhibitors for PKA (protein kinase A), but not PKG (protein kinase G), abolished cytosol-induced inhibition of MPT onset. Activity assays showed a cGMP- and cAMP-stimulated protein kinase activity in liver cytosol that was completely inhibited by PKI, a PKA peptide inhibitor. Size-exclusion chromatography of liver cytosol produced a single peak of cGMP/cAMP-stimulated kinase activity with an estimated protein size of 180–220 kDa. This fraction was PKI-sensitive and delayed onset of the MPT. Incubation of active catalytic PKA subunit directly with mitochondria in the absence of cytosol and cyclic nucleotide also delayed MPT onset, and incubation with purified outer membranes led to phosphorylation of a major 31 kDa band. After ischaemia, administration at reperfusion of membrane-permeant cAMPs and cAMP-mobilizing glucagon prevented reperfusion injury to hepatocytes. In conclusion, PKA in liver cytosol activated by cGMP or cAMP acts directly on mitochondria to delay onset of the MPT and protect hepatocytes from cell death after ischaemia/reperfusion.Keywords
This publication has 57 references indexed in Scilit:
- How to Protect Against Acetaminophen: Don't Ask for JUNKGastroenterology, 2008
- Mitochondrial Permeability Transition in Liver Ischemia and Reperfusion: Role of c-Jun N-Terminal Kinase 2Transplantation, 2008
- Minocycline and N -methyl-4-isoleucine cyclosporin (NIM811) mitigate storage/reperfusion injury after rat liver transplantation through suppression of the mitochondrial permeability transitionHepatology, 2007
- Roles of cGMP/cGMP-dependent protein kinase in platelet activationBlood, 2004
- Synergistic activation of insect cAMP‐dependent protein kinase A (type II) by cyclicAMP and cyclicGMPFEBS Letters, 2004
- Protein kinase A dependent signalling mediates anti-apoptotic effects of the atrial natriuretic peptide in ischemic liversJournal of Hepatology, 2004
- The specificities of protein kinase inhibitors: an updateBiochemical Journal, 2003
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- cDNA Cloning and Gene Expression of Human Type Iα cGMP-Dependent Protein KinaseHypertension, 1996
- Pharmacology of Protein Kinase InhibitorsAnnual Review of Pharmacology and Toxicology, 1992